Skip to main content
Clinical Trials/EUCTR2016-002859-19-NL
EUCTR2016-002859-19-NL
Active, not recruiting
Phase 1

Withdrawing off-label antipsychotics in people with intellectual disabilities: why does it fail?

Erasmus MC0 sitesSeptember 20, 2016

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
People with challenging behavior and off-label antipsychotic use
Sponsor
Erasmus MC
Status
Active, not recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 20, 2016
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Erasmus MC

Eligibility Criteria

Inclusion Criteria

  • Adults, \>18 years
  • Intellectual disability, IQ\<70
  • Living at one of the participating care\-organisations
  • Off\-label use of risperidone or pipamperone because of challenging behavior \> half year
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 125
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 1

Exclusion Criteria

  • On\-label antipsychotic use
  • Active delirium \<1 month
  • Failed antipsychotic withdrawal last 6 months
  • Use \>1 antipsychotic

Outcomes

Primary Outcomes

Not specified

Similar Trials